Discover 494 paid clinical trials in Nevada. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Nevada offers a wide array of research opportunities for both healthy participants looking to take part in paid studies, as well as for those with specific medical needs. Major research hubs in Las Vegas, Reno, and Henderson are recruiting volunteers, giving access to cutting-edge treatments and advanced healthcare.
Filter
1
Filter results
Results: 494
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sydney, Boston MA, Quebec, Massapequa NY, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Location: Raleigh NC, Durham NC, Jacksonville FL, Danville IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05647265
Phase2, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
FeaturedActive & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: New York NY, Hollywood FL, Miami FL, Orlando FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase2, Recruiting
FeaturedActive & Responsive
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
for
Bipolar I or II Disorder
Location: Cromwell CT, Springfield MA, Cedarhurst NY, Brooklyn NY,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07220460
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Cromwell CT, Springfield MA, Brooklyn NY, Toms River NJ,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
Location: Boston MA, Dracut MA, Nashua NH, Smithtown NY,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase2, Phase3, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for
Crohn's Disease
Location: New Bedford MA, New Haven CT, Quebec, Danbury CT,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06548542
Phase2, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: New York NY, Boca Raton FL, Hollywood FL, Margate FL,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase3, Recruiting
Featured
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Location: Carmel IN, The Woodlands TX, Dallas TX, Abilene TX,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07160179
Phase1, Phase2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer
Location: Ottawa, Fairfax VA, Orange City FL, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase2, Phase3, Recruiting
Featured
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for
Atopic Dermatitis
Location: Quincy MA, Boston MA, New Haven CT, Lebanon NH, Quebec,
Sponsor: AbbVie
Sex: All
Age: 18 - 63
Code: NCT06389136
Phase3, Recruiting
New
A Clinical Trial to Evaluate the Effects of a Powder Supplement in Supporting Lean Muscle Development, Hormone-Related Wellness, Digestive Comfort, Dermatologic Health, and Overall Wellness
for
Lean Muscle Development, Muscular Endurance,
Location: Las Vegas NV
Sponsor: Clean Nutraceuticals
Sex: All
Age: 21 - 45
Code: NCT07766395
Recruiting
New
Alleviant ALLAY-HF Study
for
Heart Failure
Location: Boston MA, Stony Brook NY, Montreal, New York NY,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 40+
Code: NCT05685303
Recruiting
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
for
Non Alcoholic Steatohepatitis (NASH)
Location: Halifax, New York NY, Morehead City NC, Richmond VA,
Sponsor: Axcella Health, Inc
Sex: All
Age: 18+
Code: NCT04880187
Phase2, Recruiting
PEN-866 in Patients With Advanced Solid Malignancies
for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Philadelphia PA, Bethesda MD, Fairfax VA,
Sponsor: Tarveda Therapeutics
Sex: All
Age: 18+
Code: NCT03221400
Phase1, Phase2, Recruiting
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
for
Interstitial Cystitis, Bladder Pain Syndrome
Location: Watertown MA, Lake Success NY, Hialeah FL,
Sponsor: Vaneltix Pharma, Inc.
Sex: All
Age: 18+
Code: NCT05737121
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
for
Focal Segmental Glomerulosclerosis,
Location: Quebec, New York NY, Montreal, Chapel Hill NC, Tampa FL,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT06500702
Phase2, Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Hagerstown MD, Wildwood FL, The Woodlands TX,
Sponsor: ADARx Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT06990269
Phase2, Recruiting
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab